The UK Prospective Diabetes Survey (UKPDS) demonstrated that type 2 diabetes is characterised by declining beta cell function. Achieving optimum glycaemic control becomes increasingly difficult over time and insulin continues to be the one glucose-lowering therapy that can maintain glycaemic control despite this progression.1
The aim of insulin and drug treatment for diabetes is to achieve optimum glycaemic control without frequent or severe hyperglycaemia or hypoglycaemia.
Since initiation of insulin in type 1 diabetes is essential, this article will focus on initiation of insulin in people with type 2 diabetes.
Please login or register to read the rest of the article and to have access to downloads and comments.